Ozioma C Okonkwo Selected Research

Biomarkers (Surrogate Marker)

1/2024	Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer's disease.
1/2024	CSF Biomarkers in Longitudinal Alzheimer Disease Cohorts: Pre-Analytic Challenges.
1/2023	Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4.
1/2022	Inflammation, tau pathology, and synaptic integrity associated with sleep spindles and memory prior to β-amyloid positivity.
1/2022	AD-associated CSF biomolecular changes are attenuated in KL-VS heterozygotes.
1/2022	Crosswalk study on blood collection-tube types for Alzheimer's disease biomarkers.
1/2021	Effects of Aerobic Exercise Training on Systemic Biomarkers and Cognition in Late Middle-Aged Adults at Risk for Alzheimer's Disease.
1/2021	Measurement batch differences and between-batch conversion of Alzheimer's disease cerebrospinal fluid biomarker values.
1/2018	Moderate intensity physical activity associates with CSF biomarkers in a cohort at risk for Alzheimer's disease.
1/2018	The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ozioma C Okonkwo Research Topics

Disease

34	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 11/2008
13	Cognitive Dysfunction 01/2024 - 02/2010
4	Dementia (Dementias) 01/2021 - 01/2008
4	Atrophy 01/2016 - 02/2010
3	Neuroinflammatory Diseases 01/2024 - 01/2016
3	Parkinson Disease (Parkinson's Disease) 11/2008 - 01/2008
2	Apnea 05/2024 - 01/2022
2	Inflammation (Inflammations) 01/2022 - 01/2016
2	Insulin Resistance 01/2019 - 09/2015
2	Genetic Risk Score 04/2017 - 01/2017
1	Amyloidosis 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2020
1	Down Syndrome (Down's Syndrome) 01/2019
1	Sleepiness 09/2015
1	Amyloid Plaque 09/2015
1	Sleep Apnea Syndromes (Sleep Apnea) 09/2015
1	Abdominal Obesity 07/2013
1	Disease Progression 01/2011

Drug/Important Bio-Agent (IBA)

21	Amyloid (Amyloid Fibrils)IBA 01/2024 - 01/2011
18	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2010
4	Apolipoproteins E (ApoE)IBA 01/2022 - 09/2010
4	Apolipoprotein E4IBA 10/2020 - 01/2014
4	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 07/2013
3	Amyloid beta-PeptidesIBA 01/2024 - 01/2016
3	ApolipoproteinsIBA 11/2019 - 09/2010
2	NeurograninIBA 01/2024 - 08/2017
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 05/2017
2	Insulin (Novolin)FDA Link 01/2019 - 09/2015
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 08/2017 - 01/2016
2	Chitinase-3-Like Protein 1IBA 08/2017 - 01/2016
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 09/2015 - 03/2014
2	Threonine (L-Threonine)FDA Link 01/2011 - 06/2010
1	Oxyhemoglobins (Oxyhemoglobin)IBA 05/2024
1	Angiopoietin-2IBA 01/2024
1	AD 20 (AD-20)IBA 01/2024
1	mutalipocin IIIBA 01/2024
1	SynucleinsIBA 01/2024
1	Hormones (Hormone)IBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	Edetic Acid (EDTA)FDA Link 01/2022
1	tau Proteins (tau Protein)IBA 01/2022
1	LipidsIBA 01/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2014
1	Indicators and Reagents (Reagents)IBA 01/2014
1	HDL CholesterolIBA 07/2013
1	Triglycerides (Triacylglycerol)IBA 07/2013
1	Peptides (Polypeptides)IBA 01/2011
1	amyloid beta-protein (1-42)IBA 06/2010
1	Protons (Proton)IBA 11/2008
1	Glutamic Acid (Glutamate)FDA Link 05/2008
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2008

Therapy/Procedure

1	Therapeutics 05/2017
1	Activities of Daily Living (ADL) 02/2010